New forms of diabetes drugs, known as GLP-1-based drugs, and promoted as "the new darlings of diabetes treatment" make the pharmaceutical industry billions. But are they associated with an increased risk of cancer and do ...
A former blockbuster diabetes pill that was subjected to major safety restrictions in 2010 may be less risky than once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug Avandia.
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
(AP)—The plans of a former Microsoft manager to create the "Starbucks of Pot" are worrying other activists who pushed for the legalization of marijuana in Washington state.
The government of Canada's mostly French-speaking Quebec province on Wednesday unveiled legislation allowing terminally ill patients to kill themselves with a doctor's help.
French medical authorities on Tuesday reported two new suspected cases of infection with the SARS-like virus MERS which has killed more than 30 people worldwide, the bulk of them in Saudi Arabia.
(AP)—Members of the national organization that manages organ transplants are voicing concern about a federal judge's ruling to make two sick children at a Pennsylvania hospital eligible for adult lungs.